Janda Kim

DirectorSorrento Therapeutics, Inc. (SRNE) · full profile →Form 4 · filed Sep 28, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$340K
Net Open-Market Flow
-$340K
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 27, 2021Option exercise(M)35K$1.80$63K38K
Sep 27, 2021Option exercise(M)7K$3.57$26K45K
Sep 27, 2021Sell(S)42K$8.02$340K3K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 27, 2021Option exercise(M)7K$028K
Sep 27, 2021Option exercise(M)35K$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-057957) within minutes of acceptance. Every field above traces to the original document. Verify it directly: